Krystal Biotech (KRYS) Earnings Date, Estimates & Call Transcripts → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free krys Stock Alerts $161.10 +0.87 (+0.54%) (As of 05/3/2024 08:52 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateMay. 6ConfirmedConsensus EPS (May. 6) $0.28 Listen to Call Get Krystal Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for KRYS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKRYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KRYS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Krystal Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$0.08$0.30$0.19Q2 20242$0.10$0.39$0.25Q3 20242$0.17$0.41$0.29Q4 20242$0.04$0.37$0.21FY 20248$0.39$1.47$0.93Q1 20251$0.72$0.72$0.72Q2 20251$0.87$0.87$0.87Q3 20251$1.18$1.18$1.18Q4 20251$0.92$0.92$0.92FY 20254$3.69$3.69$3.69KRYS Earnings Date and InformationKrystal Biotech last posted its earnings data on May 6th, 2024. The reported $0.00 earnings per share for the quarter, missing the consensus estimate of $0.28 by $0.28. Krystal Biotech has generated $0.08 earnings per share over the last year ($0.08 diluted earnings per share) and currently has a price-to-earnings ratio of 2,014.0. Earnings for Krystal Biotech are expected to grow by 117.58% in the coming year, from $1.82 to $3.96 per share. Krystal Biotech has confirmed that its next quarterly earnings report will be published on Monday, May 6th, 2024. Krystal Biotech will be holding an earnings conference call on Monday, May 6th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Krystal Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/6/2024Confirmed)-$0.28----- 2/26/2024Q4 2023($0.52)$0.30+$0.82$0.30$27.43 million$42.14 million 11/6/2023Q3 2023($1.10)$2.79+$3.89($4.13)$6.29 million$8.60 million 8/7/2023Q2 2023($1.27)($1.25)+$0.02($1.25)--5/8/2023Q1 2023($1.41)($1.76)($0.35)($1.76)--2/27/2023Q4 2022($1.26)($1.25)+$0.01($1.25)--11/7/2022Q3 2022($1.23)($1.17)+$0.06($1.17)-- Get the Latest News and Ratings for KRYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($1.08)($1.10)($0.02)($1.10)--5/9/2022Q1 2022($0.96)($0.99)($0.03)$0.01--2/28/2022Q4 2021($0.76)($0.94)($0.18)($0.94)-- 11/7/2021Q3 2021($0.76)($0.70)+$0.06($0.70)--8/8/2021Q2 2021($0.76)($0.74)+$0.02($0.74)--5/9/2021Q1 2021($0.62)($0.74)($0.12)($0.74)-- Krystal Biotech Earnings - Frequently Asked Questions When is Krystal Biotech's earnings date? Krystal Biotech has confirmed that its next quarterly earnings data will be published on Monday, May 6th, 2024. Learn more on KRYS's earnings history. Did Krystal Biotech beat their earnings estimates last quarter? In the previous quarter, Krystal Biotech (NASDAQ:KRYS) missed the analysts' consensus estimate of $0.28 by $0.28 with a reported earnings per share (EPS) of $0.00. Learn more on analysts' earnings estimate vs. KRYS's actual earnings. How can I listen to Krystal Biotech's earnings conference call? The conference call for Krystal Biotech's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Krystal Biotech generate each year? Krystal Biotech (NASDAQ:KRYS) has a recorded annual revenue of $50.70 million. How much profit does Krystal Biotech generate each year? Krystal Biotech (NASDAQ:KRYS) has a recorded net income of $10.93 million. KRYS has generated $0.08 earnings per share over the last four quarters. What is Krystal Biotech's price-to-earnings ratio? Krystal Biotech (NASDAQ:KRYS) has a trailing price-to-earnings ratio of 2,014.00 and a forward price-to-earnings ratio of 88.52. What is Krystal Biotech's EPS forecast for next year? Krystal Biotech's earnings are expected to grow from $1.82 per share to $3.96 per share in the next year, which is a 117.58% increase. More Earnings Resources from MarketBeat Related Companies: CRSP Earnings IMVT Earnings HALO Earnings SWTX Earnings IBRX Earnings IOVA Earnings IMCR Earnings ACLX Earnings RVMD Earnings VCEL Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:KRYS) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
